Pazopanib can preserve cosmetic quality of life even in end‐stage angiosarcoma

patients with neurogenic rosacea, all of whom had partially successful treatment with pregabalin. Given the paucity of reports on its existence, neurogenic rosacea is probably under-recognized. It should be suspected in any patients with rosacea where the predominant symptom is pain and/or burning sensation out of proportion to the flushing. We hope our report raises awareness of this potentially treatable clinical variant of rosacea, which requires a different therapeutic approach to that of other variants.